Michael Harry Barnett

52PUBLICATIONS
157CO-AUTHORS
Respiratory diseasesMedical mycologyPredictive and prognostic markersNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Aug 16, 2026
Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

|Jul 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

|Jul 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.

|Jul 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

|Jul 01, 2026
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

|Dec 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Kayla Ward, Vivien Li, Sudarshini Ramanathan

Pageof 9

Frequent Collaborators

20 joint publications

Tomas Kalincik

17 joint publications

Anneke Van der Walt

8 joint publications

Izanne Roos

6 joint publications

Jeannette Lechner-Scott